Montreal Toulouse Test With Eye Tracking in Intensive Care Unit to Evaluate Comprehension (MEXICO)

October 4, 2021 updated by: University Hospital, Tours

Montreal Toulouse 86 Test Modified to be Used With Eye Tracking: Test Automation and Eye Course in Healthy Volunteers and Intensive Care Patients

Assessment of the level of oral comprehension of the intensive care patient is essential to improve their care because they have often troubles like delirium.

Study Overview

Status

Completed

Conditions

Detailed Description

Assessment of the level of oral comprehension of the intensive care patient is essential to improve their care because they have often troubles like delirium.

Study Type

Observational

Enrollment (Actual)

113

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tours, France, 37000
        • CHU Tours

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers and patient hospitalized in intensive care unit

Description

Inclusion Criteria:

  • French speaker, RASS (Richmond Agitation-sedation scale) between -1 and +1, agree for participation

Exclusion Criteria:

  • neurovisual disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy volunteers
healthy volunteers
participant pass an eye tracking test to evaluate comprehension
intensive care patient
patient hospitalized in intensive care unit
participant pass an eye tracking test to evaluate comprehension

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Establish eye tracking standards for the test
Time Frame: during hospitalization in intensive care
fixation time measurement in the defined area of interest
during hospitalization in intensive care

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laetitia BODET-CONTENTIN, MD-PhD, University hospital of Tours

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 7, 2019

Primary Completion (Actual)

September 25, 2020

Study Completion (Actual)

September 25, 2020

Study Registration Dates

First Submitted

June 23, 2021

First Submitted That Met QC Criteria

October 4, 2021

First Posted (Actual)

October 14, 2021

Study Record Updates

Last Update Posted (Actual)

October 14, 2021

Last Update Submitted That Met QC Criteria

October 4, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • DR190027-MEXICO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Care

Clinical Trials on Montreal-Toulouse Test adapted in eye tracking

Subscribe